These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33490355)

  • 1. Paraneoplastic cerebellar degeneration associated with anti-Yo antibodies in an ovarian cancer case: A case report.
    Deac S; Stana MM; Havasi AD; Cainap C; Popita AR; Bordeianu AM; Cainap S; Bota M; Bochis OV
    Gynecol Oncol Rep; 2021 Feb; 35():100695. PubMed ID: 33490355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
    Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
    Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic cerebellar degeneration with anti-Yo antibodies and an associated submandibular gland tumor: a case report.
    Imai T; Shinohara K; Uchino K; Okuma H; Maki F; Hiruma K; Ariizumi Y; Yamano Y
    BMC Neurol; 2022 May; 22(1):165. PubMed ID: 35501715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer revealed by paraneoplastic cerebellar degeneration: a case report.
    Elomrani F; Ouziane I; Boutayeb S; Bensouda Y; Mrabti H; Errihani H
    Pan Afr Med J; 2014; 18():2. PubMed ID: 25360186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Yo antibody-positive paraneoplastic cerebellar degeneration in a patient with possible cholangiocarcinoma: A case report and review of the literature.
    Lou Y; Xu SH; Zhang SR; Shu QF; Liu XL
    World J Clin Cases; 2021 Jun; 9(17):4423-4432. PubMed ID: 34141810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Etiological Investigation of Paraneoplastic Cerebellar Degeneration in Ovarian Cancer Patients: A Systematic Review.
    Fidahussain AA; Abid A; Paracha AA; Jeevan VE; Rueve J; Engelhardt M; Schrock C; Ghani S; Nair HK
    Cureus; 2022 Nov; 14(11):e31154. PubMed ID: 36483902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian mass Presenting as Paraneoplastic cerebellar degeneration with peripheral neuropathy and anti-Yo antibody.
    Sahoo D; Dey A; Dash A; Dash A
    BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38272525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma.
    Valpione S; Zoccarato M; Parrozzani R; Pigozzo J; Giometto B; Laveder F; Aliberti C; Chiarion-Sileni V
    J Neurol Sci; 2013 Dec; 335(1-2):210-2. PubMed ID: 24035275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic cerebellar degeneration as the first evidence of malignancy: a case report.
    Kumari VA; Gupta P; Srivastava MV; Kumar L; Kriplani A; Bhatla N
    J Obstet Gynaecol Res; 2014 May; 40(5):1463-5. PubMed ID: 24689522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paraneoplastic neurologic degeneration revealing ovarian cancer recurrence].
    Zouiten O; Benbrahim Z; Amaadour L; Mellas N
    Pan Afr Med J; 2019; 33():281. PubMed ID: 31692829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic cerebellar degeneration and dermatomyositis as first manifestations of underlying breast malignancy: a report of two cases and a brief review of the subject.
    Ng YR; Ho CD; Ng WL; Tan SM
    Surg Case Rep; 2015; 1(1):59. PubMed ID: 26366356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody.
    Phuphanich S; Brock C
    J Neurooncol; 2007 Jan; 81(1):67-9. PubMed ID: 16773214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
    Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
    Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic Cerebellar Degeneration Leading to an Early Diagnosis of Peritoneal Serous Papillary Carcinoma.
    Yasuda T; Shimizu J; Miyagawa T; Tsutsumi Y; Iwatsubo T; Tsuji S
    Intern Med; 2024 Mar; ():. PubMed ID: 38432969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Yo positive paraneoplastic cerebellar degeneration in the setting of cholangiocarcinoma.
    Bruhnding A; Notch D; Beard A
    J Clin Neurosci; 2017 Feb; 36():71-72. PubMed ID: 27816258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cerebellar degeneration-related protein 2-like cell-based assay for anti-Yo detection in patients with paraneoplastic cerebellar degeneration.
    Erikstad KI; Herdlevaer I; Peter E; Haugen M; Totland C; Vedeler C
    Eur J Neurol; 2023 Jun; 30(6):1727-1733. PubMed ID: 36912432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic Cerebellar Degeneration Associated With Ovarian Adenocarcinoma: A Case Report and Review of Literature.
    Renjen PN; Chaudhari DM; Shilpi US; Zutshi D; Ahmad K
    Ann Indian Acad Neurol; 2018; 21(4):311-314. PubMed ID: 30532364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic cerebellar degeneration associated with ovarian cancer.
    Russo AE; Scalone S; Leonardi GC; Scalisi A; Giorda G; Sorio R
    Oncol Lett; 2013 Feb; 5(2):681-683. PubMed ID: 23420048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic cerebellar degeneration associated with breast cancer: A case report and review of the literature.
    Yan L; Dong X; Xu H; Huang J; Wang W; Huang L; Wan Q; Gong J
    Mol Clin Oncol; 2018 Aug; 9(2):163-167. PubMed ID: 30101014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.
    Small M; Treilleux I; Couillault C; Pissaloux D; Picard G; Paindavoine S; Attignon V; Wang Q; Rogemond V; Lay S; Ray-Coquard I; Pfisterer J; Joly F; Du Bois A; Psimaras D; Bendriss-Vermare N; Caux C; Dubois B; Honnorat J; Desestret V
    Acta Neuropathol; 2018 Apr; 135(4):569-579. PubMed ID: 29299667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.